+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
Healthy Volunteers
ID07769437

Evaluating Sucralose Effects on Gut Microbiota in Crohns Disease and Healthy Adults An Interventional Study on Non-Nutritive Sweeteners in Inflammatory Bowel Disease

Led by University Hospitals Cleveland Medical Center · Updated on 2026-09-25

40

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of the non-nutritive sweetener sucralose on gut bacteria in people with inflammatory bowel disease IBD, focusing on those with Crohns disease CD as a starting point. The study compares individuals with CD to healthy people without IBD to understand how sucralose might change the gut microbiome. Participants will follow a two-phase schedule over at least 35 days. In the first 14 days, all non-nutritive sweeteners are removed from their diet. Then, for the next 21 days, they consume sucralose at a dose of 2 sachets per day, equivalent to 2.5 mg per kg of body weight daily, which is below the acceptable daily intake. Both Crohns patients and healthy controls will participate in this intervention. During the study, participants will complete one virtual visit and two in-person visits. Researchers will collect fecal, urine, and blood samples before and after each phase to analyze changes in the gut microbiome and inflammation markers. They will measure specific outcomes such as fecal microbiome composition, myeloperoxidase activity, calprotectin levels, Crohns Disease Activity Index, and C-reactive protein. This monitoring helps understand sucraloses impact over time.

CONDITIONS

Brief Title

Non-nutritive Sweeteners in Inflammatory Bowel Disease

Research Team

A

Abigail Raffner, RD PhD

S

Sargun Singh, M.B.B.S.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here